Related Articles
Hinokitiol inhibits vasculogenic mimicry activity of breast cancer stem/progenitor cells through proteasome‑mediated degradation of epidermal growth factor receptor
Doxycycline targets aldehyde dehydrogenase‑positive breast cancer stem cells
Establishment and characterization of a triple negative basal‑like breast cancer cell line with multi‑drug resistance
Downregulation of complement factor H attenuates the stemness of MDA‑MB‑231 breast cancer cells via modulation of the ERK and p38 signaling pathways
Role of RUNX2 in breast cancer development and drug resistance (Review)